EUVIMEDEUVIMED entdecken
Crossref

Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction

Lillian W Dattilo, Emilie C M de Groot, Sarah Nyirjesy, Omar A Karadaghy iD, Elizabeth Noyes, Matthew E Spector iD, Jeremy D Richmon iD, Derrick T Lin, Mark A Varvares iD, Allen L Feng iD

Head & Neck · 2025

DOI: 10.1002/hed.28187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Lillian W Dattilo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye & Ear, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Perforator Flap, Plastic Surgery Procedures, Head and Neck Neoplasms, Free Tissue Flaps. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Minimal donor site morbidity is often cited as one of the main advantages of the medial sural artery perforator (MSAP) free flap; however, few studies have examined functional outcomes.

Methods

This retrospective cohort study analyzed patients undergoing MSAP for head and neck reconstruction from 2022 to 2024. A modified lower extremity functional scale (LEFS), with 80 being a maximum score, was administered to assess functional morbidity.

Results

Twenty two patients underwent successful MSAP flap. At < 1 month after surgery, the average LEFS was 56.0 (95% CI, 43.8–68.2). At 1–3 months, the average score was 63.0 (95% CI, 56.0–70.0); at 3–6 months, it was 75.0 (95% CI, 70.0–80.0), and at 6–12 months, it was 78.1 (95% CI, 75.4–80.0). Beyond 12 months, the average score was 79.8 (95% CI, 79.8–80.0). Conclusions and Relevance The MSAP free flap is an excellent free tissue option for head & neck reconstruction with minimal donor site morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Perforator FlapPlastic Surgery ProceduresHead and Neck NeoplasmsFree Tissue FlapsTransplant Donor SiteHumansMaleRetrospective StudiesFemaleMiddle AgedAgedAdultArteriesTreatment Outcome

Stichwörter der Autor:innen

donor site morbidityfree tissue transferhead and neck reconstructionmedial sural artery perforator free flappatient reported outcome metrics

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye & Ear, Boston, Massachusetts, USA.
  • Department of Otolaryngology, University of Kansas, Kansas City, Kansas, USA.
  • Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Omar A Karadaghy, Matthew E Spector, Jeremy D Richmon, Mark A Varvares, Allen L Feng

Zitieren

APA

Dattilo, L. W., de Groot, E. C. M., Nyirjesy, S., Karadaghy, O. A., Noyes, E., Spector, M. E., Richmon, J. D., Lin, D. T., Varvares, M. A., & Feng, A. L. (2025). Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction. Head & Neck. https://doi.org/10.1002/hed.28187

Vancouver

Dattilo LW, de Groot ECM, Nyirjesy S, Karadaghy OA, Noyes E, Spector ME, et al. Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction. Head & Neck. 2025. doi:10.1002/hed.28187

BibTeX
@article{Dattilo2025,
  author = {Dattilo, Lillian W and de Groot, Emilie C M and Nyirjesy, Sarah and Karadaghy, Omar A and Noyes, Elizabeth and Spector, Matthew E and Richmon, Jeremy D and Lin, Derrick T and Varvares, Mark A and Feng, Allen L},
  title = {Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28187}
}
Kostenlos starten →